James Franciosi, MD, MS, MSCE, on How Genetic Variations Influence PPI Therapy in Pediatric EoE

 

In this podcast, James Franciosi, MD, MS, MSCE, from Nemours Children’s Hospital, discusses the prevalence of pediatric eosinophilic esophagitis (EoE), his research on how genetic variations can differentiate responses to proton-pump inhibitor therapy in pediatric EoE, and more.

James Franciosi, MD, MS, MSCE, is chief of the Division of Gastroenterology, Hepatology and Nutrition at Nemours Children’s Hospital in Orlando, Florida.

 

Reference:

Mougey EB, Williams A, Coyne AJK, et al. CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2019;69(5):581-587. doi:10.1097/MPG.0000000000002480.

Submit Feedback

Name